These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2514309)

  • 21. Different survival determinants of metastatic breast cancer patients treated with endocrine therapy or chemo-endocrine therapy.
    Nomura Y
    Int J Oncol; 1998 Apr; 12(4):817-24. PubMed ID: 9499441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunocytochemical assay of estrogen receptors in puncture products of breast carcinomas].
    Faverly D; Querton G; Degeyter M; Lenglet G; Devleeschouwer N; Leclercq G
    Bull Cancer; 1990; 77(7):667-74. PubMed ID: 2207355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct comparisons of adjuvant endocrine therapy, chemotherapy, and chemoendocrine therapy for operable breast cancer patients stratified by estrogen receptor and menopausal status.
    Nomura Y; Shirouzu M; Takayama T
    Breast Cancer Res Treat; 1998 May; 49(1):51-60. PubMed ID: 9694611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive effect of tamoxifen as part of adjuvant chemo-endocrine therapy for breast cancer. Hokkaido Adjuvant Chemo-Endocrine Therapy for Breast Cancer Study Group.
    Uchino J; Samejima N; Tanabe T; Hayasaka H; Mito M; Hata Y; Asaishi K
    Br J Cancer; 1994 Apr; 69(4):767-71. PubMed ID: 8142265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A randomized trial of endocrine therapy, chemotherapy, and chemo-endocrine therapy in advanced breast cancer].
    Tashiro H; Nomura Y; Hisamatsu K
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2369-73. PubMed ID: 2260873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen receptors in breast cancer--therapeutic response to the treatment of recurrences.
    Pinotti JA; Teixeira LC; Pisani RC; Bastos SR
    Int J Gynaecol Obstet; 1987 Apr; 25(2):127-31. PubMed ID: 2884137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunocytochemical assay for estrogen receptor with monoclonal antibody D753P gamma in routinely processed formaldehyde-fixed breast tissue. Comparison with frozen section assay and with monoclonal antibody H222.
    Miller RT; Hapke MR; Greene GL
    Cancer; 1993 Jun; 71(11):3541-6. PubMed ID: 8490902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathologic characterization of human breast cancer in correlation with estrogen receptor status. A comparison of immunocytochemical and biochemical analysis.
    Reiner A; Reiner G; Spona J; Schemper M; Holzner JH
    Cancer; 1988 Mar; 61(6):1149-54. PubMed ID: 2830006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer.
    Remmele W; Hildebrand U; Hienz HA; Klein PJ; Vierbuchen M; Behnken LJ; Heicke B; Scheidt E
    Virchows Arch A Pathol Anat Histopathol; 1986; 409(2):127-47. PubMed ID: 2424168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to a biochemical assay and to outcome of therapy.
    McClelland RA; Berger U; Miller LS; Powles TJ; Coombes RC
    J Clin Oncol; 1986 Aug; 4(8):1171-6. PubMed ID: 2426418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiparametric study (SAMBA 200) of estrogen receptor immunocytochemical assay in 400 human breast carcinomas: analysis of estrogen receptor distribution heterogeneity in tissues and correlations with dextran coated charcoal assays and morphological data.
    Charpin C; Martin PM; De Victor B; Lavaut MN; Habib MC; Andrac L; Toga M
    Cancer Res; 1988 Mar; 48(6):1578-86. PubMed ID: 2449956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the immunocytochemical assay (ER-ICA) and the biochemical assay for estrogen receptor in human breast cancer cell lines.
    Vlatkovic L; Lykkesfeldt AE; Hou-Jensen K; Briand P
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):755-60. PubMed ID: 3653193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Change in the oestrogen receptor status of breast cancer with age--comparison of two types of assay.
    Gaskell DJ; Sangster K; Tesdale AL; Carson D; Hawkins RA
    Br J Cancer; 1992 Oct; 66(4):610-3. PubMed ID: 1419596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Detection of estrogen receptor (ER) mRNA by use of reverse transcriptase-polymerase chain reaction (RT-PCR) assay; comparison with dextran coated charcoal (DCC) assay and immunocytochemical assay].
    Ozaki T
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):361-6. PubMed ID: 1371912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunocytochemical determination of the estrogen-regulated protein Mr 24,000 in primary breast cancer and response to endocrine therapy.
    Andersen J; Skovbon H; Poulsen HS
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):641-3. PubMed ID: 2714341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen receptor analysis on biopsies and fine-needle aspirates from human breast carcinoma. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.
    Reiner A; Spona J; Reiner G; Schemper M; Kolb R; Kwasny W; Függer R; Jakesz R; Holzner JH
    Am J Pathol; 1986 Dec; 125(3):443-9. PubMed ID: 3541638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.
    Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G
    Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant chemo- and endocrine therapy alone or in combination in premenopausal patients (GABG Trial 1).
    Kaufmann M; Jonat W; Abel U
    Recent Results Cancer Res; 1989; 115():118-25. PubMed ID: 2696024
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group) trial.
    Boccardo F; Rubagotti A; Amoroso D; Sismondi P; Genta F; Nenci I; Piffanelli A; Farris A; Castagnetta L; Traina A
    Eur J Cancer; 1992; 28(2-3):673-80. PubMed ID: 1591091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Histochemical and biochemical assays of estrogen receptors in breast cancer and significance of endocrine therapy].
    Tominaga T
    Gan No Rinsho; 1983 May; 29(6):628-31. PubMed ID: 6308307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.